Italy · AIFA medicine catalogue
OPDUALAG
A source-listed package record. Different packs may share the same medicine name.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 050359013
- Form
- Concentrato per soluzione per infusione
- Composition / generic term
- NIVOLUMAB/RELATLIMAB
- Company as listed by source
- BRISTOL-MYERS SQUIBB PHARMA EEIG
- Source status
- Autorizzata
- Supply classification
- Medicinali soggetti a prescrizione medica limitativa, utilizzabili esclusivamente in ambiente ospedaliero o in una struttura ad esso assimilabile
Source-listed ingredients
- NIVOLUMAB — 240 milligrammi
- RELATLIMAB — 80 milligrammi
These values do not establish equivalence or a dose recommendation.
Packages
- 240 mg / 80 mg - Concentrato per soluzione per infusione - Uso endovenoso - Flaconcino (vetro) 20 ml (12 mg/ml / 4 mg/ml) - 1 flaconcino
Source and coverage
Open AIFA medicine catalogue →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse Italy records →